What are the indications, dosing regimens, and renal dose adjustments for fluconazole?

Fluconazole: Indications, Dosing, and Renal Adjustments

Fluconazole is indicated for invasive candidiasis, candidemia, cryptococcal meningitis, mucosal candidiasis (oropharyngeal, esophageal, vaginal), urinary tract candidiasis, and prophylaxis in high-risk patients including allogeneic HSCT recipients and post-abdominal surgery patients with recurrent perforations or anastomotic leaks. 1, 2, 3

Standard Dosing Regimens

Invasive Candidiasis and Candidemia

• Loading dose: 800 mg (12 mg/kg) on day 1
• Maintenance dose: 400 mg (6 mg/kg) once daily
• For susceptible C. glabrata infections, 800 mg (12 mg/kg) daily is often used, though not validated in trials 2, 3

Cryptococcal Meningitis

• Acute treatment: 400-800 mg (6-12 mg/kg) daily for 10-12 weeks after CSF becomes culture-negative
• Suppression in AIDS: 200 mg once daily 3

Mucosal Candidiasis

• Oropharyngeal: 200 mg day 1, then 100 mg daily for ≥14 days
• Esophageal: 200 mg day 1, then 100 mg daily (up to 400 mg may be used); treat for ≥3 weeks and ≥2 weeks after symptom resolution
• Vaginal: 150 mg single dose 3

Urinary Tract Candidiasis

• 50-200 mg daily for several weeks (fluconazole achieves urine concentrations 10-20 times serum levels, making it the preferred agent) 2, 3

Prophylaxis

• Allogeneic HSCT: 400 mg once daily from conditioning through engraftment, typically extended to day 75 post-transplant 1, 3
• Abdominal surgery (recurrent perforations/leaks): 12 mg/kg loading dose, then 6 mg/kg once daily 1

Pediatric Dosing

Use weight-based dosing with the following equivalencies: 3

• 3 mg/kg ≈ 100 mg adult dose
• 6 mg/kg ≈ 200 mg adult dose
• 12 mg/kg ≈ 400 mg adult dose (maximum 600 mg/day)

Special neonatal considerations:

• Premature neonates (26-29 weeks gestation): Administer standard mg/kg dose every 72 hours for first 2 weeks of life, then once daily thereafter due to prolonged half-life (73.6 hours initially) 3

Renal Dose Adjustments

Fluconazole is 80% renally excreted unchanged, requiring dose reduction in renal impairment. 3

Standard Renal Dosing Algorithm

1. Give full loading dose (50-400 mg based on indication) regardless of renal function 3
2. Adjust maintenance dose based on creatinine clearance:
   • CrCl >50 mL/min: 100% of standard dose
   • CrCl ≤50 mL/min (no dialysis): 50% of standard dose
   • Hemodialysis: 100% of standard dose after each dialysis session; on non-dialysis days, give 50% dose 3

Continuous Renal Replacement Therapy (CRRT)

CRRT significantly increases fluconazole clearance, requiring substantially higher doses than standard renal failure dosing. 4, 5, 6, 7

For patients on CVVHD (Continuous Veno-Venous Hemodialysis):

• Minimum dosing: 400 mg twice daily achieves target attainment in 100% of patients 6
• Fluconazole clearance during CVVHD can exceed that of healthy individuals (>2 L/h) 5
• Standard maintenance dose adjustments: multiply anuric patient dose by 3.8× for CVVHD with combined dialysate/ultrafiltrate flow of 1.5 L/h 5

For CVVH/CAVH (hemofiltration without dialysis):

• Multiply anuric dose by 2.2× for ultrafiltrate flow of 0.5 L/h 5

Critical consideration: Recent population PK modeling demonstrates that eGFR-based dosing with a loading dose of 2.8× the maintenance dose optimizes target attainment 8. The most recent evidence from 2025 shows that guideline-recommended doses (400 mg daily) fail to achieve PK/PD targets at moderate-to-high CRRT doses, necessitating individualized adjustments based on body weight and CRRT parameters 7.

Key Pharmacokinetic Properties

• Bioavailability: >90% oral (equivalent to IV) 2, 3
• Food effect: None—can be taken with or without food 3
• CSF penetration: 50-90% of plasma concentrations (superior among azoles) 2, 3
• Half-life: 30 hours (range 20-50 hours) in normal renal function; up to 46 hours in elderly 3
• Protein binding: Low (11-12%) 3
• Time to steady state: 5-10 days without loading dose; day 2 with loading dose (2× maintenance dose) 3

Critical Clinical Pitfalls

1. Do not reduce loading dose in renal failure—only maintenance doses require adjustment 3
2. CRRT patients require dramatically higher doses than standard renal failure dosing suggests; 400 mg twice daily minimum for CVVHD 6
3. Hemodialysis removes ~50% of fluconazole in 3 hours—always dose after dialysis 3
4. Azole-resistant C. glabrata and C. krusei are common—use echinocandins for empirical therapy in septic shock or critically ill patients 1
5. Do not use fluconazole for urinary tract infections in patients on lipid formulations of amphotericin B—these formulations have reduced renal excretion 2

Drug Interactions

Fluconazole inhibits cytochrome P450 enzymes, requiring careful monitoring when combined with warfarin, phenytoin, cyclosporine, oral hypoglycemics, and other CYP450 substrates. Rifampin decreases fluconazole levels 2, 9.